InsiderPulse| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-21 | 2026-04-22 | HRT FINANCIAL LP | 10% Owner | Sale | 49.7K | $0.69 | $34K | 33.6K | View ↗ | |
| 2026-04-20 | 2026-04-21 | HRT FINANCIAL LP | 10% Owner | Sale | 94.5K | $0.75 | $71K | 83.4K | View ↗ | |
| 2026-04-17 | 2026-04-21 | HRT FINANCIAL LP | 10% Owner | Purchase | 34.6K | $0.73 | $25K | 177.8K | View ↗ | |
| 2026-04-16 | 2026-04-21 | HRT FINANCIAL LP | 10% Owner | Sale | 53.9K | $0.73 | $39K | 143.2K | View ↗ | |
| 2026-04-15 | 2026-04-16 | HRT FINANCIAL LP | 10% Owner | Purchase | 92.6K | $0.76 | $70K | 197.1K | View ↗ |
No annual data found.
Most and least shorted healthcare stocks with up to $2B market cap in May
Onco-Innovations Strengthens Executive Leadership with Appointment of Dr. Islam Mohamed as Chief Medical Officer and Stephen M. Novak as Chief of Research and Development
Onconetix Highlights Realbotix's Launch of Vinci AI Vision System with Delivery of First Vinci-Equipped Humanoid Robot to Ericsson
Onco-Innovations Executes Engagement Agreement with RDI Partners and Establishes Onco-Innovations AU Pty. Ltd. to Advance Australian Phase I Strategy